Table 1 The relationship between the expression of TANs density and clinicopathological parameters in LUAD.

From: Downregulation of tropomyosin 2 promotes the progression of lung adenocarcinoma by regulating neutrophil infiltration through neutrophil elastase

Clinicopathologic features

TANs

χ2

P

 

Low (n = 121) (%)

High (n = 109) (%)

  

Sex

 Male

85

78

0.048

0.827

 Female

36

31

  

Age

 ≤60

67

49

2.49

0.115

 >60

54

60

  

Lymphatic invasion

 Yes

62

48

1.192

0.275

 No

59

61

  

Differentiation

 G1,G2

58

50

0.098

0.754

 G3

63

59

  

Lymph node metastasis

 Yes

52

68

8.658

0.003*

 No

69

41

  

TNM stage

 I, II

49

69

11.939

0.001*

 III, IV

72

40

  

Tumor size (d/cm)

 

70

  

 <4 cm

89

65

5.023

0.026*

 ≥4 cm

32

44

  

Tumor recurrence

 Yes

44

56

5.259

0.022*

 No

77

53

  
  1. P value was estimated by the Chi-square test.
  2. *P < 0.05 was considered to be statistically significant.
Back to article page